Listed

Element Solutions Inc: Form 10-Q for the period ended Sep 30, 2016

Filed with the SEC on Nov 7, 2016 and accepted by EDGAR at Nov 7, 2016, 09:06 ET.

Share

Management's discussion and analysis

As filed, 82,631 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Forward-Looking Information

From time to time, Platform may make or publish forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect Platform’s current views with respect to, among other things, future events and performance. These statements may discuss, among other things, Platform’s financial or operational results including earnings guidance, future capital expenditures, expenses, revenues, earnings, synergies, economic performance, indebtedness, financial condition, dividend policy, losses and future prospects; business and management strategies; and the effects of global economic conditions on Platform’s business. Platform generally identifies forward-looking statements by words such as “plans,” “expects,” “is expected,” “is subject to,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates,” “believes,” “targets,” “aims,” “projects” or words or terms of similar substance or the negative thereof, as well as variations of such words and phrases or statements that certain actions, events or results “may,” “could,” “should,” “would,” “might” or “will” be taken, occur or be achieved. Forward-looking statements are based on beliefs and assumptions made by management using currently available information. These statements are only predictions and are not guarantees of future performance, actions or events. Forward-looking statements are subject to risks and uncertainties. If one or more of these risks or uncertainties materialize, or if management’s underlying beliefs and assumptions prove to be incorrect, actual results may differ materially from those contemplated by a forward-looking statement. Factors that can cause actual results to differ materially from those reflected in the forward-looking statements include, among others, those discussed in Part I, Item 1A of Platform's Annual Report, Part II, Item 1A of Platform's quarterly reports on Form 10-Q for the three months ended March 31, 2016 and June 30, 2016, and this Quarterly Report, in each case under the heading "Risk Factors." You should understand that it is not possible to predict or identify all such factors. Consequently, you should not consider any such list to be a complete set of all potential risks or uncertainties, and we urge you not to place undue reliance on any forward-looking statements. The Company undertakes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise. Also, historical results are not necessarily indicative of the results expected for any future period. You are advised to consult any further disclosures we make on related subjects in the Company’s Form 10-K, 10-Q and 8-K reports filed with the SEC.

The following “Executive Overview” section is a brief summary of our recent developments, business, past acquisitions and certain significant items addressed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations. Investors should read the relevant portions of this section for a complete discussion of the events and items summarized below.

Executive Overview

We are a global, diversified producer of high-technology specialty chemical products. Our business involves the formulation of a broad range of solutions-oriented specialty chemicals, which are sold into multiple industries, including agricultural, animal health, electronics, graphic arts, plating, and offshore oil and gas production and drilling. We refer to our products as “dynamic chemistries” due to their intricate chemical compositions. Our dynamic chemistries are used in a wide variety of attractive niche markets and we believe that the majority of our operations hold strong positions in the product markets they serve.

Our strategy is to acquire and maintain leading positions in niche sectors of high-growth markets. As our name “Platform Specialty Products Corporation” implies, we continually seek opportunities to act as an acquirer and consolidator of specialty chemical businesses on a global basis, particularly those meeting our “Asset-Lite, High-Touch” philosophy, which involves prioritizing extensive resources to research and development and highly technical customer service, while managing conservatively our investments in fixed assets and capital expenditures. We regularly review acquisition opportunities and may acquire businesses that meet our acquisition criteria when we deem it to be financially prudent. To date, we have completed seven acquisitions: the MacDermid Acquisition on October 31, 2013; the Agriphar Acquisition on October 1, 2014; the CAS Acquisition on November 3, 2014; the Arysta Acquisition on February 13, 2015; the OMG Acquisition on October 28, 2015; the Alent Acquisition on December 1, 2015 and the OMG Malaysia Acquisition on January 31, 2016.

We generate revenue through the formulation and sale of our dynamic chemistries and by providing highly-technical services to our customers through our extensive global network of specially trained service personnel. Our personnel work closely with our customers to ensure that the intricate chemical composition and function of our products are maintained as intended while ensuring that these products are applied safely and effectively by users globally.

We believe that the fragmented nature of the specialty chemical products market will continue to provide significant opportunities for growth. We also believe that our combined company provides a strong platform on which to grow our business and expand our market shares in key geographic markets, particularly in emerging markets. We expect that the Acquisitions will enhance our growth by extending our products' breadth, developing higher-margin products and growing internationally. We intend to extend many of our product offerings through the development of new applications for our existing products or through synergistic combinations. Our goal is to target those geographies with attractive market fundamentals where our strengths in marketing, portfolio development, registration and customer education can add value for our customers.

On September 9, 2016, we agreed with the Arysta Seller that from October 20, 2016 until the close of business on December 15, 2016, we may settle (i) all of our obligations with respect to our shares of Series B Convertible Preferred Stock in exchange for a cash payment of $1.00 and the issuance of 5,500,000 shares of our common stock upon simultaneous conversion of the Series B Convertible Preferred Stock by the Arysta Seller, and (ii) for a payment of $460 million, our obligation to pay a “make whole payment” to the Arysta Seller pursuant to a share purchase agreement among us, the Arysta Seller and certain other parties thereto, dated as of October 20, 2014, as amended.

On September 21, 2016, we completed the September 2016 Equity Offering of 48,787,878 shares of our common stock at a public offering price of $8.25 per share. This number of shares includes 6,363,636 shares sold to the underwriters upon exercise in full of their option to purchase additional shares. The September 2016 Equity Offering was registered with the SEC pursuant to Platform's shelf registration statement on Form S-3 declared effective by the SEC on July 26, 2016. The September 2016 Equity Offering resulted in gross proceeds to Platform of approximately $402.5 million, before underwriting discounts and commissions and offering expenses of $11.6 million.

On October 14, 2016, we entered into and closed the transactions contemplated by Amendment No. 5 to the Second Amended and Restated Credit Agreement which, among other things, provided for the prepayment in full of previously existing term loans denominated in U.S. dollars and in Euros with the aggregate proceeds of newly created term loans denominated in U.S. dollars in an aggregate principal amount of $1.48 billion and term loans denominated in Euros in an aggregate principal amount of €433 million. The amendment effectively reduced interests rates by 50 basis points for the new U.S. Dollar denominated term loans and by 75 basis points for the new Euro denominated term loans, reducing annual interest payments by approximately $11.0 million. Amendment No. 5 also extended maturity from June 7, 2020 to June 7, 2023; provided that if, on or prior to November 2, 2021, we have not prepaid, redeemed or otherwise retired and/or refinanced in full the 6.50% USD Notes due 2022, as permitted under the Amended and Restated Credit Agreement, the maturity date of the new term loans will be November 2, 2021. See Note 8, Debt, Capital Leases, Financial Guarantees and Factoring Arrangements, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report, under the heading "Amended and Restated Credit Agreement - Subsequent Events."

John E. Capps joined Platform on May 31, 2016 as Executive Vice President, General Counsel and Secretary. Before joining Platform, Mr. Capps was Executive Vice President - Administration, General Counsel and Secretary of Jarden Corporation, a Fortune 500 broad-based consumer products company, where he served until April 2016 when Jarden Corporation merged with Newell Brands Inc. Previously, Mr. Capps worked with American Household, Inc., which was acquired by Jarden Corporation in January 2005, and as a private lawyer with the firm Sullivan & Cromwell LLP.

As previously disclosed in our Annual Report, in connection with the implementation of our internal controls, policies and procedures at Arysta, a newly acquired subsidiary, following our acquisition of that business we discovered certain payments made to third-party agents in connection with Arysta’s government tender business in West Africa which may be illegal or otherwise inappropriate. We have engaged outside counsel and an outside accounting firm to conduct an internal investigation to review the legality of these and other payments made in Arysta’s West Africa tender business, including Arysta’s compliance with the FCPA. We contacted the SEC and the U.S. Department of Justice to voluntarily inform them of this matter and we are fully cooperating with these governmental authorities as the investigation continues and as they review the matter. Although the internal investigation is still ongoing at the time of this Quarterly Report, based on the results to date, management does not currently believe that the amount of the payments in question, or any revenue or operating income related to those payments, are material to our business, results of operations, financial condition or liquidity.

Acquisitions

OMG Malaysia Acquisition

On January 31, 2016, we completed the OMG Malaysia Acquisition for approximately $124 million, net of acquired cash and closing working capital adjustments.

We financed the OMG Malaysia Acquisition with the proceeds from the June 2015 Equity Offering.

Alent Acquisition

On December 1, 2015, we completed the Alent Acquisition by acquiring all the issued shares of Alent for approximately $1.74 billion in cash, net of acquired cash, and 18,419,738 shares of our common stock issued to Alent shareholders, including Cevian Capital II Master Fund LP, the then largest shareholder of Alent.

We financed the Alent Acquisition with (i) available cash on hand, (ii) the proceeds from the November 2015 Notes Offering of $500 million aggregate principal amount of 10.375% USD Notes due 2021, and (iii) additional borrowings of $1.05 billion (less original issue discount of 2%) and approximately €300 million (less original discount of 2%) under our First Lien Credit Facility, and $115 million under our U.S. Dollar Revolving Credit Facility.

OMG Acquisition

On October 28, 2015, we completed the OMG Acquisition for a total purchase price of approximately $239 million in cash, net of acquired cash, and purchase price adjustments.

We financed the OMG Acquisition with the proceeds from the June 2015 Equity Offering.

Arysta Acquisition

On February 13, 2015, we completed the Arysta Acquisition for approximately $3.50 billion. The purchase price consisted of $2.86 billion in cash (net of acquired cash, closing adjustments and including Arysta Seller transaction expenses paid by Platform) and $600 million of Platform's Series B Convertible Preferred Stock issued to the Arysta Seller with a fair market value at the time of the Arysta Acquisition of $646 million. On September 9, 2016, we entered into a settlement agreement with the Arysta Seller with respect to certain of our obligations relating to the shares of Series B Convertible Preferred Stock. See Note 11, Stockholders' Equity, to our unaudited interim Condensed Consolidated Financial Statements, under the heading "Series B Convertible Preferred Stock."

We financed the Arysta Acquisition with the proceeds from (i) available cash on hand, (ii) the offering of $1.10 billion aggregate principal amount of 6.50% USD Notes due 2022 denominated in U.S. Dollars and €350 million aggregate principal amount of 6.00% EUR Notes due 2023 denominated in Euros (plus original issue premium of $1.0 million), and (iii) additional borrowings of $500 million (less original issue discount of 1%) and €83 million (less original discount of 2%) under our First Lien Credit Facility, and an additional $160 million under our U.S. Dollar Revolving Credit Facility.

Our Business

We generate revenue through the formulation and sale of our dynamic chemistries to our customers through our extensive global network of specially trained service personnel. Our personnel work closely with our customers to ensure that the chemical composition and function of our dynamic chemistries are maintained as intended.

While our dynamic chemistries typically represent only a small portion of our customers’ costs, we believe that they are critical to our customers’ manufacturing processes and overall product performance. Further, operational risks and switching costs make it difficult for our customers to change suppliers, which grants us an advantage in retaining customers and maintaining our market positions.

Business Segments

Our operations are organized into two reportable segments: Performance Solutions and Agricultural Solutions. The reporting segments represent businesses for which separate financial information is utilized by the chief operating decision maker, or CODM, for the purpose of allocating resources and evaluating performance. Each of the reportable segments has its own president, who reports to the CODM.

Performance Solutions

Our Performance Solutions segment formulates and markets dynamic chemistry solutions that are used in electronics, automotive production, oil and gas production, drilling, and commercial packaging and printing. Our products include surface and coating materials, functional convention coatings, electronic assembly materials, water-based hydraulic control fluids and photopolymers. In conjunction with the sale of these products, we provide extensive technical service and support when necessary to ensure superior performance of their application. Within this segment, we provide specialty chemicals to the following industries: Electronics, Electronics Assembly Materials, Industrial, Offshore and Commercial Packing and Printing. For the Electronics industry, we design and formulate a complete line of proprietary “wet” dynamic chemistries that our customers use to process the surface of printed circuit boards and other electronic components they manufacture. For the Electronics Assembly Materials industry, we develop, manufacture and sell innovative interconnected materials, primarily in the electronics market, used to assemble printed circuit boards and advanced semiconductor packaging. We also offer a small water treatment product line. For the Industrial industry, our dynamic chemistries are used for finishing, cleaning and providing surface coatings for a broad range of metal and non-metal surfaces which improve the performance or look of a component of an industrial part or process. For the Offshore industry, we produce water-based hydraulic control fluids for major oil and gas companies and drilling contractors for offshore deep water production and drilling applications. For the Commercial Packaging and Printing industries, we produce photopolymers through an extensive line of flexographic plates, used to produce printing plates for transferring images onto commercial packaging, including packaging for consumer food products, pet food bags, corrugated boxes, labels and beverage containers. In addition, we also produce photopolymer printing plates for the flexographic and letterpress newspaper and publications markets.

Agricultural Solutions

Our Agricultural Solutions segment is based on a solutions-oriented business model that focuses on product innovation to address an ever-increasing need for higher crop yield and quality. We offer to growers diverse crop protection solutions from weeds (herbicides), insects (insecticides) and diseases (fungicides), in foliar and seed treatment applications. We also offer a wide variety of proven biosolutions, including biostimulants, which stimulate plant growth and reproductive development, innovative nutrition, which optimizes the nutrition of plants, and biocontrol products, such as bioinsecticides and biofungicides, which perform the same task as conventional crop protection products without chemical residues. We emphasize farmer economics and food safety by combining, when possible, biosolutions with crop protection and seed treatment agrochemicals. Our Global Value Added Portfolio, or GVAP, consists of agrochemicals in the herbicides, insecticides, fungicides and seed treatment categories, based on patented or proprietary off-patent AIs. Our Global BioSolutions Portfolio, or GBP, includes biostimulants, innovative nutrition and biocontrol products. In addition, we offer regional off-patent AIs and certain non-crop products, including animal health products, such as honey bee protective miticides and certain veterinary vaccines.

Our business segments include significant foreign operations. There are certain risks associated with our foreign operations. See Part II, Item 1A Risk Factors – “Our substantial international operations subject us to risks not faced by domestic competitors” included in this Quarterly Report.

We sell our products worldwide. Because our segments may utilize shared facilities and administrative resources and offer products that are distinct from one another, we make decisions about how to manage our operations by reference to each segment and not with respect to the underlying products or geographic regions that comprise each segment.

Results of Operations

The following table summarizes the results of operations for the three and nine months ended September 30, 2016 and 2015:

(amounts in millions)

Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Net sales $890.5 $597.3 $2,635.9 $1,807.3
Cost of sales 515.4 354.6 1,524.1 1,088.8
Gross profit 375.1 242.7 1,111.8 718.5
Selling, technical, general and administrative 274.3 194.8 823.5 593.2
Research and development 20.9 16.6 61.3 47.8
Operating profit 79.9 31.3 227.0 77.5
Interest expense, net (98.5) (52.7) (289.7) (143.2)
Other income (expense), net 104.9 (82.8) 51.8 (49.4)
Income tax expense (20.4) (35.4) (65.7) (59.8)
Net income (loss) $65.9 $(139.6) $(76.6) $(174.9)

In addition, our other comprehensive income increased by $363 million and $1.03 billion for the three and nine months ended September 30, 2016 and 2015, driven primarily by changes in foreign currency translation gains associated with the Brazilian Real on a quarterly basis and the Brazilian Real, British Pound, Euro and Japanese Yen on a year-to-date basis.

The following table summarizes the results of operations for the three and nine months ended September 30, 2016 and 2015 by reportable segment:

(amounts in millions)

Performance Solutions Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Net sales $454.9 $179.7 $1,312.9 $541.6
Cost of sales 251.8 86.5 736.7 259.1
Gross profit 203.1 93.2 576.2 282.5
Selling, technical, general and administrative 120.9 50.5 372.5 159.0
Research and development 10.6 5.4 34.1 16.9
Operating profit $71.6 $37.3 $169.6 $106.6
Agricultural Solutions
Net sales $435.6 $417.6 $1,323.0 $1,265.7
Cost of sales 263.6 268.1 787.9 828.9
Gross profit 172.0 149.5 535.1 436.8
Selling, technical, general and administrative 135.0 113.7 370.8 349.5
Research and development 10.3 11.2 27.2 30.9
Operating profit $26.7 $24.6 $137.1 $56.4

Non-GAAP Financial Measures

In this Management’s Discussion and Analysis of Financial Condition and Results of Operations section, we present certain financial measures related to our business that are "non-GAAP financial measures" within the meaning of Item 10 of Regulation S-K. Such non-GAAP financial measures include adjusted net sales change, adjusted cost of sales change, adjusted gross profit change, adjusted selling, technical, general and administrative expense change, adjusted research and development expense change and adjusted operating profit change, in each case adjusted for the OMG Malaysia, Alent and OMG Acquisitions for all periods presented and changes in foreign currency translations. We believe these non-GAAP financial measures provide useful information about our operating performance by excluding certain items that we believe are not representative of our business and including other items that we believe are useful in evaluating our business. We also believe that these financial measures provide investors with measures that allow them to more readily assess our performance, including, among other things, giving investors additional information regarding our organic performance without giving effect to the OMG Malaysia, Alent and OMG Acquisitions and the impact of translating foreign currencies into U.S. Dollars and the impact of currency rate changes on certain foreign currency denominated transactions. However, these non-GAAP financial measures should be considered in addition to, and not a substitute for, the financial information that we report in accordance with GAAP.

The adjustments for the OMG Malaysia, Alent and OMG Acquisitions were as follows:

(amounts in millions)

Three Months Ended September 30, 2016 Nine Months Ended September 30, 2016
Net sales $280.2 $795.3
Cost of sales 171.0 494.1
Gross profit 109.2 301.2
Selling, technical, general and administrative 62.1 202.4
Research and development 5.8 19.3
Operating profit 41.3 79.5

The adjustments for changes in foreign currency translations consisted of converting our current-period local currency financial results into U.S. Dollars using the prior period's exchange rates and comparing these adjusted amounts to our prior period reported results. The weakening Brazilian Real, British Pound and Mexican Peso most notably contributed to the nine month year-over-year results, offset in part by the strengthening Japanese Yen. The same currencies had similar effects on a quarterly year-over-year basis, with the exception of the Brazilian Real, which significantly appreciated during the third quarter of 2016 compared to 2015.

We believe that these adjustments provide a more meaningful basis of comparison of our results on a year-over-year basis, consistent with how we evaluate our performance.

Three and nine months ended September 30, 2016 versus the three and nine months ended September 30, 2015.

Net Sales

(amounts in millions)

Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Net sales $890.5 $597.3 $2,635.9 $1,807.3

For the three months ended September 30, 2016, net sales totaled $891 million, representing an increase of $293 million, or 49.1%, as compared to the same period in 2015. For the nine months ended September 30, 2016, net sales totaled $2.64 billion, representing an increase of $829 million, or 45.8%, as compared to the same period in 2015.

(amounts in millions)

Three Months Ended September 30, 2016 $ Change % Change Nine Months Ended September 30, 2016 $ Change % Change
Total change $293.2 49.1% $828.6 45.8%
- acquisitions (280.2) (46.9)% (795.3) (44.0)%
- foreign currency translation (6.7) (1.1)% 60.7 3.4%
Change, adjusted for acquisitions and foreign currency translation $6.3 1.1% $94.0 5.2%

For the three months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, net sales increased by $6.3 million, or 1.1%. For the nine months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, net sales increased by $94.0 million, or 5.2%.

(amounts in millions)

Performance Solutions Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Net sales $454.9 $179.7 $1,312.9 $541.6
- acquisitions (280.2) — (795.3) —
- foreign currency translation 3.0 — 13.8 —
Net sales, adjusted for acquisitions and foreign exchange $177.7 $179.7 $531.4 $541.6
Agricultural Solutions
Net sales $435.6 $417.6 $1,323.0 $1,265.7
- foreign currency translation (9.7) — 46.9 —
Net sales, adjusted for foreign exchange $425.9 $417.6 $1,369.9 $1,265.7

Performance Solutions' net sales in the third quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $178 million, representing a decrease of $2.0 million, or 1.1%, as compared to the third quarter of 2015. The decrease in net sales was driven predominantly by general softness in the offshore business primarily in the U.S. and European regions due to decreases in the price of oil, which resulted in delays of project startups. The impact of oil prices was twofold: (1) reduced demand for offshore production control and drilling fluids, and (2) reduced demand for plating chemistry sold into the supply chain for onshore oil production rigs and stripping/cleaning chemistry utilized in polyethylene terephthalate recycling.

Performance Solutions' net sales for the nine months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, totaled $531 million, representing a decrease of $10.2 million, or 1.9%, as compared to the nine months ended September 30, 2015. The decrease in net sales was driven by softness in the offshore U.S. and European markets, due to lower fills and maintenance product activity.

Agricultural Solutions' net sales in the third quarter of 2016, adjusted for foreign currency translation, totaled $426 million, representing an increase of $8.3 million, or 2.0%, as compared to the third quarter of 2015. The increase is primarily related to increased volumes of herbicides and fungicides in Europe, gains in Asia that coincided with a strategic shift to increase sales of proprietary brands over generic alternatives, growth in sales for insecticides suited for specialty crops in the United States, and continued growth in anti-malarial insecticides in Africa. These effects were partially offset by our continued integration efforts to reduce volumes related to low-margin products across geographic markets.

Agricultural Solutions' net sales for the nine months ended September 30, 2016, adjusted for foreign currency translation, totaled $1.37 billion, representing an increase of $104 million, or 8.2%, as compared to the nine months ended September 30, 2015. The increase in net sales on a comparable basis was primarily driven by volume and pricing growth in our insecticide and herbicide businesses in Latin America and Europe, our anti-malarial insecticides in Africa, and our biosolutions business, along with management's focus on price growth via an increase in sales of proprietary brands. These effects were partially offset by lower volumes in North America, mainly due to falling farmer incomes and soft demand, as well as our continued integration efforts to reduce volumes related to low-margin products across geographic markets.

Cost of Sales

(amounts in millions)

Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Cost of sales $515.4 $354.6 $1,524.1 $1,088.8

For the three months ended September 30, 2016, cost of sales totaled $515 million, or 57.9% of net sales, as compared to $355 million, or 59.4% of net sales, during the same period in 2015, representing an increase of $161 million. For the nine months ended September 30, 2016, cost of sales totaled $1.52 billion, or 57.8% of net sales, as compared to $1.09 billion, or 60.2% of net sales, during the same period in 2015, representing an increase of $435 million.

(amounts in millions)

Three Months Ended September 30, 2016 $ Change % Change Nine Months Ended September 30, 2016 $ Change % Change
Total change $160.8 45.3% $435.3 40.0%
- acquisitions (171.0) (48.2)% (494.1) (45.4)%
- foreign currency translation (4.9) (1.4)% 33.7 3.1%
Change, adjusted for acquisitions and foreign currency translation $(15.1) (4.3)% $(25.1) (2.3)%

For the three months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, cost of sales decreased by $15.1 million, or 4.3%. For the nine months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, cost of sales decreased by $25.1 million, or 2.3%.

(amounts in millions)

Performance Solutions Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Cost of sales $251.8 $86.5 $736.7 $259.1
- acquisitions (171.0) — (494.1) —
- foreign currency translation 1.0 — 5.7 —
Cost of sales, adjusted for acquisitions and foreign exchange $81.8 $86.5 $248.3 $259.1
Agricultural Solutions
Cost of sales $263.6 $268.1 $787.9 $828.9
- foreign currency translation (5.9) — 28.0 —
Cost of sales, adjusted for foreign exchange $257.7 $268.1 $815.9 $828.9

Performance Solutions' cost of sales in the third quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $81.8 million, as compared to $86.5 million in the third quarter of 2015, representing a decrease of $4.7 million, or 5.4%. The decrease in cost of sales related primarily to lower adjusted sales volume in the third quarter of 2016 associated with our Offshore business and lower procurement costs for raw materials resulting from management's integration efforts.

Performance Solutions' cost of sales for the nine months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, totaled $248 million, as compared to $259 million for the nine months ended September 30, 2015, representing a decrease of $10.8 million, or 4.2%, due primarily to the aforementioned lower adjusted sales volume, lower material costs from achieved synergies and favorable product mix.

Agricultural Solutions' cost of sales in the third quarter of 2016, adjusted for foreign currency translation, totaled $258 million, as compared to $268 million in the third quarter of 2015, representing a decrease of $10.4 million, or 3.9%. The decrease included the impact of purchase accounting related to the step-up of inventory that was sold during the third quarter of 2015, which totaled $1.3 million. Excluding the effect of purchase accounting, cost of sales decreased by $9.1 million. The decrease was driven primarily by continued integration efforts and cost management strategies that produced more favorable procurement pricing from vendors, especially in Latin America, production process efficiencies derived from infrastructure improvements in Europe, and the reduction of certain low-margin product volumes across geographic markets.

Agricultural Solutions' cost of sales for the nine months ended September 30, 2016, adjusted for foreign currency translation, totaled $816 million, as compared to $829 million for the nine months ended September 30, 2015, representing a decrease of $13.0 million, or 1.6%. The decrease included the impact of purchase accounting related to the step-up of inventory that was sold during the nine months of 2015, which totaled $58.0 million. Excluding the effect of purchase accounting, cost of sales increased by $45.0 million. The increase was primarily driven by higher overall sales volume and the exclusion of costs of sales incurred prior to the Arysta Acquisition in February 2015. On a comparable basis, cost of sales declined for the nine months ended September 30, 2016, primarily due to the third quarter activity discussed in the preceding paragraph, as cost of sales for the first six months of 2016 was relatively flat compared to the same period of 2015.

Gross Profit

(amounts in millions)

Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Gross profit $375.1 $242.7 $1,111.8 $718.5

For the three months ended September 30, 2016, gross profit totaled $375 million, or 42.1% of net sales, as compared to $243 million, or 40.6% of net sales, during the same period in 2015, representing an increase of $132 million. For the nine months ended September 30, 2016, gross profit totaled $1.11 billion, or 42.2% of net sales, as compared to $719 million, or 39.8% of net sales, during the same period in 2015, representing an increase of $393 million.

(amounts in millions)

Three Months Ended September 30, 2016 $ Change % Change Nine Months Ended September 30, 2016 $ Change % Change
Total change $132.4 54.6% $393.3 54.7%
- acquisitions (109.2) (45.0)% (301.2) (41.9)%
- foreign currency translation (1.8) (0.7)% 27.0 3.8%
Change, adjusted for acquisitions and foreign currency translation $21.4 8.8% $119.1 16.6%

For the three months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, gross profit increased $21.4 million, or 8.8%. For the nine months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, gross profit increased $119 million, or 16.6%.

(amounts in millions)

Performance Solutions Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Gross profit $203.1 $93.2 $576.2 $282.5
- acquisitions (109.2) — (301.2) —
- foreign currency translation 2.0 — 8.1 —
Gross profit, adjusted for acquisitions and foreign exchange $95.9 $93.2 $283.1 $282.5
Agricultural Solutions
Gross profit $172.0 $149.5 $535.1 $436.8
- foreign currency translation (3.8) — 18.9 —
Gross profit, adjusted for foreign exchange $168.2 $149.5 $554.0 $436.8

Performance Solutions' gross profit in the third quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $95.9 million, as compared to $93.2 million in the third quarter of 2015, representing an increase of $2.7 million, or 2.9%. The increase in gross profit primarily related to a shift in product mix, as management focuses on continued cost savings realized from integration efforts, which were partially offset by a decrease of $2.0 million in net sales.

Performance Solutions' gross profit for the nine months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, totaled $283 million, and was essentially flat when compared to the nine months ended September 30, 2015. The lower sales volume when compared to the first nine months of 2015 was partially offset by gross margin expansion from lower raw material purchases through synergies and favorable product mix.

Agricultural Solutions' gross profit in the third quarter of 2016, adjusted for foreign currency translation, totaled $168 million, as compared to $150 million in the third quarter of 2015, representing an increase of $18.7 million, or 12.5%. The increase is primarily driven by an overall increase in sales volume coupled with a more favorable product mix and continued reduction in procurement costs due to integration efforts and cost management.

Agricultural Solutions' gross profit for the nine months ended September 30, 2016, adjusted for foreign currency translation, totaled $554 million, as compared to $437 million for the nine months ended September 30, 2015, representing an increase of $117 million, or 26.8%. The increase is largely a result of the exclusion of gross profit earned in 2015 prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, gross profit increased primarily due to a broad increase in sales volumes and pricing. These increases are partially offset by soft demand in North America, where volumes fell as a result of declining farmer incomes and lower demand. We continue to see favorable effects from improved procurement trends, product mix and our focus on proprietary products and more profitable growing niche markets.

Selling, Technical, General and Administrative Expense

(amounts in millions)

Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Selling, technical, general and administrative $274.3 $194.8 $823.5 $593.2

For the three months ended September 30, 2016, selling, technical, general and administrative expense totaled $274 million, or 30.8% of net sales, as compared to $195 million, or 32.6% of net sales, during the same period in 2015, representing an increase of $79.5 million. For the nine months ended September 30, 2016, selling, technical, general and administrative expense totaled $824 million, or 31.2% of net sales, as compared to $593 million, or 32.8% of net sales, during the same period in 2015, representing an increase of $230 million.

(amounts in millions)

Three Months Ended September 30, 2016 $ Change % Change Nine Months Ended September 30, 2016 $ Change % Change
Total change $79.5 40.8% $230.3 38.8%
- acquisitions (62.1) (31.9)% (202.4) (34.1)%
- foreign currency translation 3.0 1.5% 23.4 3.9%
Change, adjusted for acquisitions and foreign currency translation $20.4 10.5% $51.3 8.6%

For the three months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, selling, technical, general and administrative expense increased by $20.4 million, or 10.5%. The increase is due to increased segment level costs, partially offset by a reduction in corporate spending related to acquisition and integration activities.

For the nine months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, selling, technical, general and administrative expense increased by $51.3 million, or 8.6%. The increase was due in part to additional investments made in our corporate infrastructure, especially related to acquisition and integration activities during the first quarter of 2016, aimed at supporting increased demands driven by our substantial growth, including increases in headcount and professional fees, and higher segment-level costs, as discussed below. These increases were partially offset by lower acquisition and integration-related costs incurred at the corporate level.

(amounts in millions)

Performance Solutions Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Selling, technical, general and administrative expense $120.9 $50.5 $372.5 $159.0
- acquisitions (62.1) — (202.4) —
- foreign currency translation 0.8 — 3.9 —
Selling, technical, general and administrative expense, adjusted for acquisitions and foreign exchange $59.6 $50.5 $174.0 $159.0
Agricultural Solutions
Selling, technical, general and administrative expense $135.0 $113.7 $370.8 $349.5
- foreign currency translation 2.2 — 19.5 —
Selling, technical, general and administrative expense, adjusted for foreign exchange $137.2 $113.7 $390.3 $349.5

50

Performance Solutions' selling, technical, general and administrative expense in the third quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $59.6 million as compared to $50.5 million in the third quarter of 2015, representing an increase of $9.1 million, or 18.0%. The increase is primarily due to additional third-party professional fees, restructuring costs and administrative expenses in connection with integrating and managing the acquired businesses. These increases are partially offset by reductions in overhead and headcount associated with management's integration efforts.

Performance Solutions' selling, technical, general and administrative expense for the nine months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, totaled $174 million, as compared to $159 million for the nine months ended September 30, 2015, representing an increase of $15.0 million, or 9.4%. The increase is due primarily to the integration-related activity discussed in the preceding paragraph.

Agricultural Solutions' selling, technical, general and administrative expense in the third quarter of 2016, adjusted for foreign currency translation, totaled $137 million, as compared to $114 million in the third quarter of 2015, representing an increase of $23.5 million, or 20.7%. The increase was due primarily to expenses related the expansion of our businesses, such as sales bonuses, commissions and product promotion expenses. We also incurred additional overhead as we continue to integrate our businesses and develop the appropriate operational infrastructure to support further growth.

Agricultural Solutions' selling, technical, general and administrative expense for the nine months ended September 30, 2016, adjusted for foreign currency translation, totaled $390 million, as compared to $350 million for the nine months ended September 30, 2015, representing an increase of $40.8 million, or 11.7%. The increase is largely a result of the exclusion of 2015 selling, technical, general and administrative expenses prior to the Arysta Acquisition on February 13, 2015. On a comparable basis, related expenses declined for the first nine months of 2016 compared to the same period in 2015. The decline is largely the result of management's realization of synergies associated with acquisitions and focus to control spending. These activities have offset the increase in growth-related and infrastructural expenditures.

Research and Development Expense

(amounts in millions)

Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Research and development expense $20.9 $16.6 $61.3 $47.8

For the three months ended September 30, 2016, research and development expense totaled $20.9 million, or 2.3% of net sales, as compared to $16.6 million, or 2.8% of net sales, during the same period in 2015, representing an increase of $4.3 million. For the nine months ended September 30, 2016, research and development expense totaled $61.3 million, or 2.3% of net sales, as compared to $47.8 million, or 2.6% of net sales, during the same period in 2015, representing an increase of $13.5 million.

(amounts in millions)

Three Months Ended September 30, 2016 $ Change % Change Nine Months Ended September 30, 2016 $ Change % Change
Total change $4.3 25.9% $13.5 28.2%
- acquisitions (5.8) (34.9)% (19.3) (40.4)%
- foreign currency translation 0.2 1.2% 1.6 3.3%
Change, adjusted for acquisitions and foreign currency translation $(1.3) (7.8)% $(4.2) (8.8)%

For the three months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, research and development expense decreased by $1.3 million, or 7.8%. For the nine months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, research and development expense decreased by $4.2 million, or 8.8%.

(amounts in millions)

Performance Solutions Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Research and development expense $10.6 $5.4 $34.1 $16.9
- acquisitions (5.8) — (19.3) —
- foreign currency translation — — 0.1 —
Research and development expense, adjusted for acquisitions and foreign exchange $4.8 $5.4 $14.9 $16.9
Agricultural Solutions
Research and development expense $10.3 $11.2 $27.2 $30.9
- foreign currency translation 0.2 — 1.5 —
Research and development expense, adjusted for foreign exchange $10.5 $11.2 $28.7 $30.9

Performance Solutions' research and development expense in the third quarter of 2016, adjusted for acquisitions, totaled $4.8 million, as compared to $5.4 million in the third quarter of 2015, representing a decrease of $0.6 million, or 11.1%. For the nine months ended September 30, 2016, research and development expense, adjusted for acquisitions and foreign currency translation, totaled $14.9 million, as compared to $16.9 million for the nine months ended September 30, 2015, representing a decrease of $2.0 million, or 11.8%. The decrease in both periods is driven by integration activities that have reduced research and innovation-related operating costs.

Agricultural Solutions' research and development expense in the third quarter of 2016, adjusted for foreign currency translation, totaled $10.5 million, as compared to $11.2 million in the third quarter of 2015, representing a decrease of $0.7 million, or 6.3%. For the nine months ended September 30, 2016, adjusted for foreign currency translation, research and development expense totaled $28.7 million, as compared to $30.9 million for the nine months ended September 30, 2015, representing a decrease of $2.2 million, or 7.1%. The decrease in research and development expense in both periods is largely due to the integration of research and development functions of the acquisitions into the legacy business and management's continued focus on cost controls.

Operating Profit

(amounts in millions)

Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Operating profit $79.9 $31.3 $227.0 $77.5

For the three months ended September 30, 2016, operating profit totaled $79.9 million, or 9.0% of net sales, as compared to $31.3 million, or 5.2% of net sales, during the same period in 2015, representing an increase of $48.6 million. For the nine months ended September 30, 2016, operating profit totaled $227 million, or 8.6% of net sales, as compared to $77.5 million, or 4.3% of net sales, during the same period in 2015, representing an increase of $150 million.

(amounts in millions)

Three Months Ended September 30, 2016 $ Change % Change Nine Months Ended September 30, 2016 $ Change % Change
Total Change $48.6 155.3% $149.5 192.9%
- acquisitions (41.3) (131.9)% (79.5) (102.6)%
- foreign currency translation (5.0) (16.0)% 2.1 2.7%
Change, adjusted for acquisitions and foreign currency translation $2.3 7.3% $72.1 93.0%

For the three months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, operating profit increased by $2.3 million. For the nine months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, operating profit increased by $72.1 million.

(amounts in millions)

Performance Solutions Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Operating profit $71.6 $37.3 $169.6 $106.6
- acquisitions (41.3) — (79.5) —
- foreign currency translation 1.2 — 4.1 —
Operating Profit, adjusted for acquisitions and foreign exchange $31.5 $37.3 $94.2 $106.6
Agricultural Solutions
Operating profit $26.7 $24.6 $137.1 $56.4
- foreign currency translation (6.2) — (2.0) —
Operating profit, adjusted for foreign exchange $20.5 $24.6 $135.1 $56.4

Performance Solutions' operating profit in the third quarter of 2016, adjusted for acquisitions and foreign currency translation, totaled $31.5 million, as compared to $37.3 million in the third quarter of 2015, representing a decrease of $5.8 million, or 15.5%. Performance Solutions' operating profit for the nine months ended September 30, 2016, adjusted for acquisitions and foreign currency translation, totaled $94.2 million, as compared to $106.6 million for the nine months ended September 30, 2015, representing a decrease of $12.4 million, or 11.6%. The decrease for both periods was due primarily to higher selling, general, technical and administrative expenses related to integration activities, partially offset by modest increases in gross profit during both periods.

Agricultural Solutions' operating profit in the third quarter of 2016, adjusted for foreign currency translation, totaled $20.5 million, as compared to $24.6 million in the third quarter of 2015, representing an increase of $4.1 million, or 16.7%. The increase was driven primarily by the increase in gross profit, partially offset by increases in selling, technical, general and administrative expenditures tied to costs associated with the expansion of our businesses.

Agricultural Solutions' operating profit for the nine months ended September 30, 2016, adjusted for foreign currency translation, totaled $135 million, as compared to $56.4 million for the nine months ended September 30, 2015, representing an increase of $78.7 million. The increase is due in part to the exclusion of 2015 operating results prior to the Arysta Acquisition on February 13, 2015, as well as the impact of inventory purchase accounting in 2015 of $58.0 million. On a comparable basis, operating profit improvements were driven primarily by the increase in gross profits, complemented by reductions in selling, technical, general and administrative expenditures and research and development costs, resulting from integration efforts and management oversight.

Other (Expense) Income

(amounts in millions)

Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Interest expense, net $(98.5) $(52.7) $(289.7) $(143.2)
Loss on derivative contracts (1.4) (47.3) (12.1) (49.9)
Foreign exchange loss (10.3) (36.9) (56.5) (19.3)
Other income, net 116.6 1.4 120.4 19.8
Total other expense $6.4 $(135.5) $(237.9) $(192.6)

Interest Expense, Net

For the three months ended September 30, 2016 and 2015, net interest expense totaled $98.5 million and $52.7 million, respectively, representing an increase of $45.8 million. For the nine months ended September 30, 2016 and 2015, net interest expense totaled $290 million and $143 million, respectively, representing an increase of $147 million. The increase in both periods relates primarily to interest charges resulting from incremental debt facilities used to fund the Alent Acquisition, including the November 2015 Notes Offering of $500 million, borrowings of $1.05 billion (less original issue discount of 2%) and approximately €300 million (less original discount of 2%) under our First Lien Credit Facility. In addition, the year-to-date increase also includes a full first quarter's impact in 2016 of the interest expense related to the incremental debt facilities used to fund the Arysta Acquisition.

Loss on Derivative Contracts

For the three months ended September 30, 2016 and 2015, loss on derivative contracts totaled $1.4 million and $47.3 million, respectively, representing a decrease in loss of $45.9 million. The decrease in loss is mainly due to the settlement in prior year's fourth quarter of a deal contingent foreign exchange contract associated with the Alent Acquisition, which had a balance of $48.1 million at September 30, 2015. The remaining change is due to normal volatility of the underlying currency exchange rates and commodities prices being hedged. For the nine months ended September 30, 2016 and 2015, loss on derivative contracts totaled $12.1 million and $49.9 million, respectively, representing a decrease in loss of $37.8 million. The decrease in loss is due mainly to the aforementioned $48.1 million unrealized loss on a deal contingent forward contract settled in prior year, partially offset by our increased use of foreign exchange and commodities derivative contracts to better manage our market risks coupled with an increase in the volatility of certain foreign exchange rates, particularly the Brazilian Real, and of prices of certain commodities, particularly silver.

Foreign Exchange Gain (Loss)

For the three months ended September 30, 2016 and 2015, foreign exchange loss totaled $10.3 million and $36.9 million, respectively, representing a decrease of $26.6 million. The third quarter of 2016 includes $12.0 million of foreign exchange loss associated with the remeasurement of foreign denominated external and intercompany debt related to the Acquisitions, compared to a loss of $33.0 million in the third quarter 2015.

For the nine months ended September 30, 2016 and 2015, foreign exchange loss totaled $56.5 million and $19.3 million, respectively, representing an increase of $37.2 million. The nine months of 2016 include $58.7 million of foreign exchange losses associated with the remeasurement of foreign denominated external and intercompany debt related to the Acquisitions, compared to a loss of $26.8 million for the same period in 2015.

Other Income, Net

For the three months ended September 30, 2016 and 2015, other income, net totaled $117 million and $1.4 million, respectively, representing an increase of $115 million. The increase related primarily to a gain of $103 million from the settlement agreement related to our Series B Convertible Preferred Stock, a $6.0 million gain associated with the remeasurement of the Preferred Series B redemption liability recorded during the third quarter of 2016, as well as a $3.5 million gain on the sale of our 15% equity interest in Certis Europe B.V.

For the nine months ended September 30, 2016 and 2015, other income, net totaled $120 million and $19.8 million, respectively, representing an increase of $101 million. The increase was primarily driven by a legal settlement gain totaling $16.0 million and the expiration of an acquisition-related put option on our common stock in connection with the Agriphar Acquisition totaling $3.0 million in the first nine months of 2015 as compared to a gain of $103 million from the settlement agreement with the Arysta seller, a $6.0 million gain associated with the remeasurement of the Series B Convertible Preferred Stock redemption liability recorded, a $2.8 million legal settlement, and a $3.5 million gain on the sale of our 15% equity interest in Certis Europe B.V. recorded during the first nine months of 2016.

Income Tax

(amounts in millions)

Three Months Ended September 30, 2016 2015 Nine Months Ended September 30, 2016 2015
Income tax expense $(20.4) $(35.4) $(65.7) $(59.8)
Effective tax rate 23.6% (34.0)% (602.8)% (52.0)%

For the three months ended September 30, 2016, income tax expense totaled $20.4 million, compared to an income tax expense of $35.4 million for the three months ended September 30, 2015. Our effective tax rate for the three months ended September 30, 2016 was 23.6% on pre-tax income of $86.3 million, compared to an effective tax rate of (34.0)% on pre-tax loss of $104 million for the three months ended September 30, 2015. The difference between the statutory and effective tax rates for the three months ended September 30, 2016 primarily related to the recognition of a $38.2 million benefit for a nontaxable purchase price adjustment related to the Arysta acquisition, a $25.6 million benefit for deductions related to the Alent Acquisition, and a $15.3 million benefit related to the recognition of tax deductible goodwill. Partially offsetting these items was a $21.9 million valuation allowance on current quarter losses that may not be recoverable for U.S. and foreign companies, a $26.0 million increase in tax reserves primarily for deductions related to the Alent Acquisition, and a $14.7 million charge related to tax on foreign operations. The difference from the statutory to effective tax rates for the three months ended September 30, 2015 primarily relates to a tax expense of $33.9 million for U.S. tax on foreign operations and $33.9 million related to non-deductible transactional costs.

The change in the effective tax rate from (34.0)% for the three months ended September 30, 2015 to 23.6% for the three months ended September 30, 2016 is attributable to a disproportionate change in pre-tax income, primarily the gain from the settlement agreement related to the Series B Convertible Preferred Stock in 2016.

For the nine months ended September 30, 2016 and 2015, income tax expense totaled $65.7 million and $59.8 million, respectively. Our effective tax rate for the nine months ended September 30, 2016 was (602.8)% on pre-tax loss of $10.9 million, compared to an effective tax rate of (52.0)% on pre-tax loss of $115 million for the nine months ended September 30, 2015. The difference between the statutory and effective tax rates for the nine months ended September 30, 2016 primarily related to the recognition of a $103 million valuation allowance on current period losses that may not be recoverable for U.S. and foreign companies, a $27.9 million increase in tax reserves primarily for deductions related to the Alent Acquisition, and a $10.0 million charge related to tax on foreign operations. Partially offsetting these items was a $38.2 million benefit for a nontaxable purchase price adjustment related to the Arysta Acquisition, a $25.6 million benefit for deductions associated with the Alent Acquisition, and a $15.3 million benefit related to the recognition of tax deductible goodwill. The difference from the statutory to effective tax rates for the nine months ended September 30, 2015 primarily relates to a tax expense for the establishment of a $21.5 million valuation allowance on foreign tax credit carryovers as a result of the impact of the Arysta Acquisition, $28.0 million for U.S. tax on foreign operations, a $11.0 million foreign rate differential and losses that did not produce tax benefits and $34.9 million related to non-deductible transactional costs.

The change in the effective tax rate from (52.0)% for the nine months ended September 30, 2015 to (602.8)% for the nine months ended September 30, 2016 is attributable to a disproportionate change in pre-tax income, primarily the gain from the settlement agreement related to the Series B Convertible Preferred Stock in 2016.

Liquidity and Capital Resources

In order to fund our acquisition activity, we have $5.28 billion of debt as of September 30, 2016, with expected interest payments in excess of $300 million per year. Our first significant principal debt payments, totaling $3.22 billion, are due in 2020 and represent maturities of our outstanding term loans under our Amended and Restated Credit Agreement. In October 2016, we entered into and closed the transactions contemplated by Amendment No. 5 to the Second Amended and Restated Credit Agreement which, among other things, provided for the prepayment in full of previously existing term loans denominated in U.S. dollars and in Euros with the aggregate proceeds of newly created term loans denominated in U.S. dollars in an aggregate principal amount of $1.48 billion and term loans denominated in Euros in an aggregate principal amount of €433 million. The amendment effectively reduced interest rates by 50 basis points for the new U.S. Dollar denominated term loans and by 75 basis points for the new Euro denominated term loans, while extending maturity by three years to June 7, 2023; provided that if, on or prior to November 2, 2021, we have not prepaid, redeemed or otherwise retired and/or refinanced in full the 6.50% USD Notes due 2022 as permitted under the Amended and Restated Credit Agreement, the maturity date of the new term loans will be November 2, 2021. See Note 8, Debt, Capital Leases, Financial Guarantees and Factoring Arrangements, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report, under the heading "Amended and Restated Credit Agreement - Subsequent Events."

In addition, under the terms of a settlement agreement with the Arysta Seller, from October 20, 2016 until the close of business on December 15, 2016, we may settle (i) all of our obligations with respect to the Series B Convertible Preferred Stock in exchange for a cash payment of $1.00 and the issuance of 5,500,000 shares of our common stock upon simultaneous conversion of the Series B Convertible Preferred Stock by the Arysta Seller, and (ii) for a payment of $460 million, our obligation to pay the make whole payment mentioned below to the Arysta Seller. To the extent we do not settle all of our obligations by December 15, 2016, we will be required, on April 20, 2017, to repurchase, in consideration and exchange for shares of our common stock, each share of Series B Convertible Preferred Stock that has not been previously converted into shares of our common stock or automatically redeemed for cash. Upon such repurchase, we may also pay to holders of Series B Convertible Preferred Stock in cash a make-whole payment, which corresponds to any deficit between (i) the 10-day volume weighted price of Platform’s common stock prior to such repurchase and (ii) $27.14 per share. This make-whole payment, which varies based on our stock price, corresponds to a maximum amount of $600 million. As of September 30, 2016, this maximum make-whole payment was approximately $421 million.

We anticipate sufficient cash from operations to fund interest, working capital and other capital expenditures for the foreseeable future and have access to a $500 million line of credit under our Revolving Credit Facility, with current availability of $500 million, as well as availability under various lines of credit and overdraft facilities of $118 million. In addition, during the third quarter of 2016, we completed the September 2016 Equity Offering of 48,787,878 shares of common stock. This offering resulted in gross proceeds of approximately $402.5 million.

Despite the above, a combination of the settlement of the preferred stock redemption liability, working capital shortfalls and future acquisitions may require utilization of our Revolving Credit Facility as well as proceeds from future debt and/or equity offerings. Our long-term liquidity may be impacted by our ability to borrow additional funds, renegotiate existing debt and/or raise equity or debt under terms that are favorable to us. Our long-term liquidity may also be impacted by the pending withdrawal of the United Kingdom (U.K.) from the E.U., commonly referred to as "Brexit." In June 2016, a referendum was held in which voters approved the exit from the E.U. As a result, it is expected that the British government will begin negotiating the terms of the U.K.'s withdrawal from the E.U. A withdrawal could cause disruption and uncertainty surrounding our business, including affecting our relationships with our existing and future customers, suppliers and employees in the U.K. and in other countries in the E.U. The announcement of Brexit also caused significant volatility in global stock markets and fluctuations in currency exchange rates that resulted in the strengthening of the U.S. Dollar against foreign currencies in which we conduct business. The strengthening of the U.S. Dollar relative to other currencies may adversely affect our business, financial conditions or results of operations, and expose us to gains and losses on non-U.S. currency transactions. This volatility in foreign currencies is expected to continue as the U.K. negotiates and executes its exit from the E.U. but it is uncertain over what time period this will occur. Any of these effects of Brexit, among others, could adversely affect our business, financial condition, operating results and cash flows.

Our primary sources of liquidity during the nine months ended September 30, 2016 were proceeds received from the September 2016 Equity Offerings, periodic borrowings under our Revolving Credit Facility and available cash. Our primary uses of cash and cash equivalents were operating expenses, capital expenditures and debt service obligations. We believe that our cash and cash equivalent balance, cash generated from operations and availability under our Revolving Credit Facility will be sufficient to meet our working capital needs, capital expenditures and other business requirements for at least the next twelve months. Pending any future acquisitions, however, we may require additional borrowings against our Revolving Credit Facility, as well as future debt and/or equity offerings. At September 30, 2016, we had $714 million in cash and cash equivalents in addition to availability under our Revolving Credit Facility and lines of credit of $618 million.

Of our $714 million of cash and cash equivalents at September 30, 2016, $523 million was held by our foreign subsidiaries. The laws of certain countries may limit our ability to utilize cash resources held in those countries for operations in other countries. However, these laws are not likely to impact our liquidity in a material way. The operations of each foreign subsidiary generally fund such subsidiary’s capital requirements. In the event that other foreign operations or operations within the United States require additional cash, we may transfer cash between and among subsidiaries as needed so long as such transfers are in accordance with law. As of September 30, 2016, we had the ability to repatriate $23.1 million at our discretion from the foreign subsidiaries and branches while the remaining balance of $499 million was held at subsidiaries in which earnings are considered permanently reinvested. Repatriation of some of these funds could be subject to delays and could have potential tax consequences, principally with respect to withholding taxes paid in foreign jurisdictions. If cash is repatriated from jurisdictions in which earnings are considered permanently reinvested we will be required to accrue and pay U.S. income taxes on such repatriations.

On January 31, 2016, we completed the OMG Malaysia Acquisition for approximately $124 million, net of acquired cash and closing working capital adjustments, subject to purchase price adjustments. We acquired OMG Malaysia to add-on to the OMG Acquisition and further enhance our Performance Solutions segment. See Note 2, Acquisitions of Businesses, to our interim Condensed Consolidated Financial Statements included in this Quarterly Report for further detail.

We may from time to time seek to retire or purchase our outstanding debt, including, but not limited to, our Senior Notes, through cash purchases, exchanges for equity securities, or refinancing, in open market purchases, privately negotiated transactions or otherwise. Such repurchases or exchanges, if any, will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors.

The following is a summary of our cash flows (used in) provided by operating, investing and financing activities during the periods indicated:

(amounts in millions)

Nine Months Ended September 30, 2016 2015
Cash and cash equivalents, beginning of the period $432.2 $397.3
Cash (used in) provided by operating activities (24.0) 131.1
Cash used in investing activities (37.5) (2,305.8)
Cash provided by financing activities 337.4 2,481.0
Exchange rate impact on cash and cash equivalents 6.0 (21.6)
Cash and cash equivalents, end of the period $714.1 $682.0
Key operating metrics
Days sales outstanding (DSO) 117 121
Days in Inventory (DII) 100 114

Operating Activities

During the nine months ended September 30, 2016, cash used in operating activities totaled $24.0 million, compared to cash provided by operating activities of $131 million during the nine months ended September 30, 2015. This year-over-year change was driven by higher cash income which was more than offset by a $190 million unfavorable change in cash used for assets and liabilities, net of acquisitions. The major drivers of the unfavorable change in assets and liabilities were decreases in our accounts payable and accrued expenses related to timing of payments to suppliers and, to a lesser extent, non-working capital assets and liabilities. Partially offsetting this cash usage was a modest improvement in inventories.

Investing Activities

Cash flows used in investing activities totaled $37.5 million during the nine months ended September 30, 2016, as compared to $2.31 billion used during the nine months ended September 30, 2015. The decrease was largely due to $2.86 billion of net cash outflows related primarily to the Arysta Acquisition on February 13, 2015, which was partially offset by a release of $600 million in acquisition-related restricted cash. Additionally, during the nine months ended September 30, 2016, capital expenditures and investments in product registration rights were $3.1 million lower when compared to the same period in 2015.

Financing Activities

Cash flows provided by financing activities totaled $337 million during the nine months ended September 30, 2016, as compared to $2.48 billion during the nine months ended September 30, 2015. The decreased financing activity cash inflows were primarily related to the financing of the Arysta Acquisition, which included proceeds of $2.09 billion from borrowings and $470 million from the issuance of common stock. Offsetting these 2015 inflows were payments of debt financing fees associated primarily with the Arysta Acquisition of $45.5 million. Additionally, on a year-over-year basis, our factored liabilities decreased cash flows by $28.7 million and we made additional repayments of debt of $10.5 million. Partially offsetting these year-over-year reduced cash inflows was a stock issuance in the third quarter 2016 that generated net proceeds of $392 million and $14.2 million of increased borrowings under our revolving credit facilities during the nine months ended September 30, 2016.

Financial Borrowings

Credit Facilities

As of September 30, 2016, we had $5.28 billion of indebtedness, which included $1.96 billion of Senior Notes and $3.26 billion of term debt arrangements outstanding under our First Lien Credit Facility; $42.8 million under our overdraft lines of credit; and $11.2 million of stand-by letters of credit, which reduce the borrowings available under our Revolving Credit facility. Availability under our Revolving Credit Facility and various lines of credit and overdraft facilities totaled $618 million as of September 30, 2016.

Alent Acquisition

In connection with the Alent Acquisition, we completed the November 2015 Notes Offering of $500 million in aggregate principal amount of 10.375% USD Notes due 2021. The notes are governed by an indenture, dated November 10, 2015, as amended from time to time, bear interest at a rate of 10.375% and mature on May 1, 2021, unless redeemed earlier. In addition, we borrowed $1.05 billion (less original issue discount of 2%) and €300 million (less original issue discount of 2%) under our First Lien Credit Facility, and $115 million under our multi-currency Revolving Credit Facility.

Arysta Acquisition

In connection with the Arysta Acquisition, we completed the February 2015 Notes Offering of $1.10 billion aggregate principal amount of 6.50% USD Notes due 2022, plus original issue premium of $1.0 million, and €350 million aggregate principal amount of 6.00% EUR Notes due 2023. The notes are governed by an indenture, dated February 2, 2015, as amended from time to time. The 6.50% USD Notes due 2022 and the 6.00% EUR Notes due 2023 mature on February 1, 2022 and February 1, 2023, respectively, unless redeemed earlier. The 6.50% USD Notes due 2022 and the 6.00% EUR Notes due 2023 bear interest at a rate of 6.50% and 6.00% per year, respectively, until maturity. In addition, we borrowed $500 million (less original issue discount of 1%) and €83.0 million (less original issue discount of 2%) under our First Lien Credit Facility, and $160 million under our U.S. Dollar Revolving Credit Facility.

CAS Acquisition

In connection with the CAS Acquisition, in August 2014, we borrowed $130 million and €205 million under our First Lien Credit Facility, $60.0 million under our U.S. Dollar Revolving Credit Facility, and €55.0 million under our multicurrency Revolving Credit Facility.

Agriphar Acquisition

In connection with the Agriphar Acquisition, in October 2014, we borrowed $300 million under our First Lien Credit Facility.

MacDermid Acquisition

In connection with the MacDermid Acquisition, in October 2013, under its First Lien Credit Agreement, MacDermid, with Platform as co-borrower, borrowed $373 million in connection with the repayment of the $360 million in principal on its then second lien credit facility.

Our Credit Facilities contain various covenants, including limitations on additional indebtedness, dividends and other distributions, entry into new lines of business, use of loan proceeds, capital expenditures, restricted payments, restrictions on liens, transactions with affiliates, amendments to organizational documents, accounting changes, sale and leaseback transactions and dispositions. In addition, our Revolving Credit Facility requires compliance with certain financial covenants, including a first lien net leverage ratio of no greater than 6.25 to 1.0 of (x) consolidated indebtedness secured by a first lien minus unrestricted cash and cash equivalents of the borrowers and guarantors under the Amended and Restated Credit Agreement to (y) consolidated EBITDA for the four most recent fiscal quarters, subject to a right to cure. As of September 30, 2016, the Company was in compliance with the debt covenants contained in our Credit Facilities.

Contractual Obligations and Commitments

The contractual obligations and commitments disclosures have not changed materially from those disclosed in our Annual Report, except as indicated below. For a discussion of our contractual obligations and commitments, refer to Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," contained in our Annual Report.

The proportion of liabilities measured at fair value using significant level 3 inputs comprised about 94.5% and 84.0% of total liabilities measured at fair value as of September 30, 2016 and December 31, 2015, respectively. See Note 10, Fair Value Measurements, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report.

Amendment No. 5 to the Second Amended and Restated Credit Agreement

On October 14, 2016, we entered into and closed the transactions contemplated by Amendment No. 5 to the Second Amended and Restated Credit Agreement which, among other things, provided for the prepayment in full of previously existing term loans denominated in U.S. dollars and in Euros with the aggregate proceeds of newly created term loans denominated in U.S. dollars in an aggregate principal amount of $1.48 billion and term loans denominated in Euros in an aggregate principal amount of €433 million. The amendment effectively reduced interest rates by 50 basis points for the new U.S. Dollar denominated term loans and by 75 basis points for the new Euro denominated term loans, reducing annual interest payments by approximately $11.0 million. Amendment No. 5 also extended maturity from June 7, 2020 to June 7, 2023; provided that if, on or prior to November 2, 2021, we have not prepaid, redeemed or otherwise retired and/or refinanced in full the 6.50% USD Notes due 2022 as permitted under the Amended and Restated Credit Agreement, the maturity date of the new term loans will be November 2, 2021. See Note 8, Debt, Capital Leases, Financial Guarantees and Factoring Arrangements, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report, under the heading "Amended and Restated Credit Agreement - Subsequent Events."

Series B Convertible Preferred Stock

In connection with the Arysta Acquisition, we issued to the Arysta Seller 600,000 shares of Series B Convertible Preferred Stock, which have a $1,000 per share liquidation preference. To the extent we do not settle all of our obligations pursuant to the settlement agreement mentioned below, at any time after December 15, 2016, the Arysta Seller has the ability to convert these shares into shares of common stock of Platform at a conversion price of $27.14 per share. Additionally, any shares that have not previously been converted will be automatically redeemed at a $1,000 redemption price in the event of certain mergers or consolidations, the sale of all or substantially all of our assets or subsidiaries, the sale of certain subsidiaries or the approval of any plan for the dissolution, liquidation or termination of Platform by its stockholders. Under the terms of a settlement agreement with the Arysta Seller, from October 20, 2016 until the close of business on December 15, 2016, we may settle (i) all of our obligations with respect to the Series B Convertible Preferred Stock in exchange for a cash payment of $1.00 and the issuance of 5,500,000 shares of our common stock upon simultaneous conversion of the Series B Convertible Preferred Stock by the Arysta Seller, and (ii) for a payment of $460 million, our obligation to pay the make whole payment mentioned below to the Arysta Seller. To the extent we do not settle all of our obligations by December 15, 2016, we will be required, on April 20, 2017, to repurchase each share of Series B Convertible Preferred Stock that has not been converted into shares of common stock of Platform, or automatically redeemed, as described above. Upon such repurchase, we would also pay to holders of Series B Convertible Preferred Stock in cash a make whole payment, which corresponds to any deficit between (i) the 10-day volume weighted price of Platform’s common stock prior to such repurchase and (ii) $27.14 per share. Based on Platform's common stock price of $8.11 as of September 30, 2016, the maximum potential make whole payment would total approximately $421 million. To the extent we do not settle all of our obligations by December 15, 2016, the holders of Series B Convertible Preferred Stock are also entitled to an incremental payment equal to $4.0 million per month from October 20, 2016 to April 20, 2017, or such earlier date after October 20, 2016 that the then outstanding shares of Series B Convertible Preferred Stock are converted into shares of common stock of Platform or automatically redeemed by us for cash.

The contractual obligations and commitments table reported in Part II, Item 7, "Management's Discussion and Analysis of Financial Condition and Results of Operations," contained in our Annual Report, does not include our Series B Convertible Preferred Stock obligations, including the estimated make whole payment, described above.

Off-Balance Sheet Transactions

We use customary off-balance sheet arrangements, such as operating leases and letters of credit, to finance our business. As a result of ASU No. 2016-02, “Leases,” for fiscal years and interim periods beginning after December 15, 2018, we will be required to record lease liabilities and right-of-use assets for all of our qualifying operating leases that are currently treated as off-balance sheet transactions.

There are no other arrangements that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.

Recent Accounting Pronouncements

A summary of recent accounting pronouncements in included in Note 1, Basis of Presentation and Significant Accounting Policies, to our unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report.

Market risk

As filed, 1,398 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The quantitative and qualitative disclosures about market risk required by this item have not changed materially from those disclosed in our Annual Report, except as indicated below. For a discussion of our exposure to market risk, refer to Part II, Item 7A, "Quantitative and Qualitative Disclosures about Market Risk," contained in our Annual Report.

Foreign Currency Risk

The announcement of the Referendum of the United Kingdom’s Membership of the E.U., often referred to as "Brexit," advising for the exit of the United Kingdom from the E.U., caused significant volatility in global stock markets and currency exchange rate fluctuations that resulted in the strengthening of the U.S. Dollar against foreign currencies in which we conduct business. The strengthening of the U.S. Dollar relative to other currencies may adversely affect our business, financial condition, or results of operations, and expose us to gains and losses on non-U.S. currency transactions. In addition, a potential devaluation of the local currencies of our customers relative to the U.S. Dollar may impair the purchasing power of our customers and could cause customers to decrease or cancel orders or default on payments. This volatility in foreign currencies is expected to continue as the United Kingdom negotiates and executes its exit from the E.U., but it is uncertain over what time period this will occur.

Controls and procedures

As filed, 6,435 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining disclosure controls and procedures as defined in Rules 13a-15 (e) and 15d-15(e) under the Exchange Act. As required by Rule 13a-15(b) of the Exchange Act, management, including our CEO and CFO, has evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Based on that evaluation, our CEO and CFO have concluded that the Company’s disclosure controls and procedures were not effective due to material weaknesses in our internal control over financial reporting previously identified by our management and described more fully under Item 9A of our Annual Report.

The material weaknesses in our internal control relating to insufficient complement of personnel with an appropriate level of accounting knowledge, experience and training commensurate with our financial reporting requirements, as further described in our Annual Report, continued to exist as of the end of the period covered by this Quarterly Report. These material weaknesses resulted to date in the restatement of the unaudited interim financial statements previously issued in our quarterly report on Form 10-Q for the quarter ended March 31, 2015 as a result of an error related to the Arysta Acquisition, as described in the 2016 Q1 Form 10-Q, and the restatement of income taxes in the unaudited interim financial statements previously issued in our quarterly report on Form 10-Q for the quarter ended September 30, 2015, as described in our Annual Report.

Our management is actively engaged in implementing the remediation initiatives described in our Annual Report, 2016 Q1 Form 10-Q and 2016 Q2 Form 10-Q which are designed to address these material weaknesses. Our ongoing remediation efforts include the implementation of the following previously stated initiatives:

  • implementation of a global consolidation and planning system;
  • implementation of control processes relating to newly-acquired businesses and non-routine transactions;
  • implementation of enhanced monitoring controls relating to the financial reporting and performance of our newly-acquired businesses;
  • enhancement of our financial planning and analysis function within our businesses and at the corporate level;
  • addition of further qualified resources to our corporate and segment staff;
  • enhancement of the controllership function in our newly-acquired businesses; and
  • continued recruiting efforts to hire qualified personnel.

In addition, as part of our remediation efforts related to the accounting for income taxes, we have completed the implementation of a global tax reporting system during the first quarter of 2016

While significant progress has been made, additional time is necessary to fully implement and demonstrate the effectiveness of these remediation initiatives and until remediated, the material weaknesses described above could result in material misstatements of our annual or interim consolidated financial statements that would not be prevented or detected. We are committed to operating effective controls, and management continues to regularly assess the progress and sufficiency of the ongoing initiatives and make adjustments as and when necessary.

Notwithstanding the aforementioned material weaknesses, our management believes that the unaudited interim Condensed Consolidated Financial Statements included in this Quarterly Report fairly represent, in all material respects, our results of operations, financial position, and cash flows as of and for the periods presented, each in accordance with GAAP. Based in part on our continuing efforts, our CEO and CFO have included their certifications as exhibits to this Quarterly Report.

Our management has excluded from the evaluation of disclosure controls and procedures as of September 30, 2016 the internal control over financial reporting related to Alent, the OMG Businesses and OMG Malaysia because they were acquired by Platform in purchase business combinations consummated during the fourth quarter of 2015 with respect to Alent and the OMG Businesses and the first quarter of 2016 with respect to OMG Malaysia. Alent's, the OMG Businesses' and OMG Malaysia's total assets, excluding goodwill and intangible assets recognized in purchase accounting, and total revenues represent approximately 23% and 31%, respectively, of the related unaudited interim Condensed Consolidated Financial Statement amounts as of and for the quarter ended September 30, 2016. These acquisitions are material to our results of operations, financial condition and cash flows, and the integration following these business combinations is likely to materially impact the Company's internal control over financial reporting. We are in process of evaluating the internal controls over financial reporting for these acquisitions as required by the above stated Rules.

(b) Changes to Internal Control Over Financial Reporting

As required by Rule 13a-15(d) under the Exchange Act, our management, including our CEO and CFO, has evaluated the Company’s internal control over financial reporting to determine whether any changes occurred during the quarter covered by this Quarterly Report have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

There have been no changes that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting during the quarter covered by this Quarterly Report.

Risk factors

As filed, 23,367 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Except as set forth below, there have been no material changes to the risk factors set forth in Part I, Item 1A of our Annual Report under the heading "Risk Factors."

We have numerous equity instruments outstanding that could require us to issue additional shares of common stock. Therefore, you may experience significant dilution of your ownership interests and the future issuance of additional shares of our common stock, or the anticipation of such issuances, could have an adverse effect on our stock price.

We have numerous equity instruments outstanding that would require us to issue additional shares of our common stock. Depending on the equity instrument, these additional shares may either be issued for no additional consideration or based on a fixed amount of additional consideration. Specifically, as of September 30, 2016, we had outstanding the following:

  • 2,000,000 shares of Series A Preferred Stock which are convertible into shares of our common stock, on a one-for-one basis, at any time at the option of the holder;
  • 600,000 shares of Series B Convertible Preferred Stock, issued in connection with the Arysta Acquisition which, to the extent we do not settle all of our obligations pursuant to the settlement agreement mentioned below, are convertible into up to 22,107,590 shares of our common stock at any time after December 15, 2016 by the Arysta Seller. Each share of Series B Convertible Preferred Stock will also be automatically redeemed in connection with certain mergers or consolidations, the sale of all or substantially all of the assets of Platform and its subsidiaries, the sale of certain subsidiaries of Platform, or a dissolution, liquidation or termination of Platform. Under the terms of a settlement agreement with the Arysta Seller, from October 20, 2016 until the close of business on December 15, 2016, we may settle (i) all of our obligations with respect to the Series B Convertible Preferred Stock in exchange for a cash payment of $1.00 and the issuance of 5,500,000 shares of our common stock upon simultaneous conversion of the Series B Convertible Preferred Stock by the Arysta Seller, and (ii) for a payment of $460 million, our obligation to pay the make whole payment mentioned below to the Arysta Seller. To the extent we do not settle all of our obligations by December 15, 2016, we will be required, on April 20, 2017, pursuant to a share purchase agreement among us, the Arysta Seller and certain other parties thereto, dated as of October 20, 2014, as amended, to repurchase each share of Series B Convertible Preferred Stock that has not been converted into shares of common stock of Platform, or automatically redeemed as described above. Upon such repurchase, we shall also pay to holders of Series B Convertible Preferred Stock in cash a make whole payment corresponding to any deficit between (i) the 10-day volume weighted price of our common stock prior to such repurchase and (ii) $27.14 per share. The related potential cash obligation, which varies based on our stock price, corresponds to a maximum amount of $600 million. Based on our common stock price of $8.11 as of September 30, 2016, the maximum potential make whole payment as of September 30, 2016 would total approximately $421 million;
  • 7,997,665 exchange rights which require us to issue shares of our common stock in exchange for shares of common stock of our subsidiary, PDH, on a one-for-one basis, at the option of the holder;
  • approximately 565,198 options which are exercisable to purchase shares of our common stock, on a one-for-one basis, at any time at the option of the holder, of which 390,198 shares were issued under the 2013 Plan; and
  • approximately 2,433,966 RSUs which were granted to employees under our 2013 Plan. Each RSU represents a contingent right to receive one (1) share of our common stock.

We have approximately 12,302,402 shares of our common stock currently available under our 2013 Plan, net of the outstanding RSUs and options noted above (subject to increase in accordance with the terms of such plan) and 373,434 shares issued under the 2013 Plan, and an additional 5,026,150 shares of our common stock currently available under our 2014 ESPP.

In addition, the holders of our Series A Preferred Stock are entitled to receive an annual dividend on their Series A Preferred Stock in the form of shares of our common stock. For 2015, no stock dividend was declared with respect to their Series A Preferred Stock. Since December 31, 2014, the dividend amount is calculated based on the appreciated stock price compared to the highest dividend price (calculated based upon the average of the last ten trading days of the year’s volume weighted average share prices) previously used in calculating the Series A Preferred Stock dividends. In 2014, the dividend price was $22.85. Such issuance of common stock as stock dividend in the future could have a dilutive impact on, and reduce the value of, our outstanding common stock.

We have restated our unaudited interim condensed consolidated financial statements previously issued in our quarterly report on Form 10-Q for the quarter ended March 31, 2015.

As further described in Note 20, Restatement of Unaudited Interim Condensed Consolidated Financial Statements (Unaudited) to the unaudited interim Condensed Consolidated Financial Statements included in the 2016 Q1 Form 10-Q, we previously disclosed in our quarterly report on Form 10-Q for the quarter ended June 30, 2015 an error to goodwill and foreign currency translation adjustment of $72.8 million related to the Arysta Acquisition, which was corrected as an out-of-period adjustment in such quarterly report. We subsequently concluded that this previously disclosed error also had the effect of understating cash flows provided by operating activities and cash flows used in investing activities by $72.8 million and therefore further concluded that the previously reported information should no longer be relied upon. As a result, we restated our unaudited interim financial information for our first quarter ended March 31, 2015 in the aforementioned Note 20. If we are required to restate previously issued financial statements for any additional periods, such restatement could impair our reputation, could cause a loss of investor confidence and adversely materially affect our business, financial condition, or results of operations.

Volatility of the trading prices of our common stock and/or Senior Notes could adversely affect our security holders.

The trading prices of our common stock and Senior Notes have been highly volatile and could continue to be subject to wide fluctuations in response to various factors, some of which are beyond our control, including, but not limited to:

  • quarterly variations in our operating results;
  • changes in the market’s expectations about our operating results;
  • our operating results failing to meet the expectation of management, securities analysts or investors in a particular period;
  • the failure to remediate identified material weaknesses;
  • changes in financial estimates and recommendations by securities analysts concerning our Company or our industry in general;
  • operating and securities price performance of companies that investors deem comparable to us;
  • news reports and publication of research reports relating to our business or trends in our markets;
  • changes in laws and regulations affecting our businesses;
  • announcements or strategic developments, acquisitions and other material events by us or our competitors;
  • sales of substantial amounts of common stock by our directors, executive officers or significant stockholders or the perception that such sales could occur;
  • adverse market reaction to any additional debt we incur in the future;
  • litigation and class action proceedings;
  • the failure to identify and complete acquisitions in the future or unexpected difficulties or developments related to the integration of recently completed, pending or future acquisitions;
  • actions by institutional stockholders;
  • general economic and political conditions such as business cycles, recessions and acts of war or terrorism; and
  • other matters discussed in this Quarterly Report.

In addition, the stock market in general, and the market for specialty chemicals companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors may seriously affect the market price of companies’ stock, including ours, regardless of actual operating performance. In addition, in the past, following periods of volatility in the overall market and the market price of particular companies’ securities, securities litigation and class action proceedings have often been instituted against such companies. A shareholder derivative action and a class action lawsuit of these types were filed against us in April and March 2016, respectively. There can be no assurance that the market price of our common stock and/or Senior Notes will not fall in the future due to any of the aforementioned factors.

Failure to comply with the FCPA and other similar anti-corruption laws could subject us to penalties and damage our reputation.

We are subject to the FCPA, the Bribery Act, and other anti-corruption laws that generally prohibit companies, directors, officers, employees, and their intermediaries from making corrupt payments to foreign officials for the purpose of obtaining or retaining business or securing an improper advantage. Under many of these laws, companies may also be held liable for actions taken by third-parties acting on their behalf, such as strategic or local partners or representatives. Certain anti-corruption laws, including the Bribery Act, also prohibit commercial bribery and the receipt of bribes, while others, such as the FCPA, require companies to maintain accurate books and records and adequate internal controls. Certain of the jurisdictions in which we conduct business are perceived to have a heightened risk for corruption, extortion, bribery, pay-offs, theft and other improper practices. We also count governments among our customers, which increases our risks under the FCPA, the Bribery Act and other laws. Our businesses prohibit bribery and unethical conduct, but these policies may not prevent our employees or agents from violating these laws in contravention of our policies. Failure by us, our employees or our intermediaries to comply with applicable anti-corruption laws, governmental authorities in the United States or elsewhere, as applicable, may result in civil and/or criminal penalties against us, our officers or our employees, or prohibitions on the conduct of our business, all of which could damage our reputation and have a material adverse effect on our business, financial condition and results of operations. Any determination that our operations or activities, including our licenses or permits, importing or exporting, product testing or registrations, or sales and marketing are not in compliance with existing laws or regulations could result in the imposition of substantial fines, civil and criminal penalties, interruptions of business, modification of business practices and compliance programs, loss of supplier, vendor or other third-party relationship, termination of necessary licenses and permits, and other legal or equitable sanctions, including disgorgement, injunctive relief and other sanctions that we may take against our personnel or that may be taken against us or our personnel.

As previously disclosed in our 2015 Annual Report, in connection with the implementation of our internal controls, policies and procedures at Arysta, a newly acquired subsidiary, following our acquisition of that business we discovered certain payments made to third-party agents in connection with Arysta’s government tender business in West Africa which may be illegal or otherwise inappropriate. We have engaged outside counsel and an outside accounting firm to conduct an internal investigation to review the legality of these and other payments made in Arysta’s West Africa tender business, including Arysta’s compliance with the FCPA. We contacted the SEC and the U.S. Department of Justice to voluntarily inform them of this matter and we are fully cooperating with these governmental authorities as the investigation continues and as they review the matter. Because the internal investigation and compliance reviews are ongoing, there can be no assurance as to how the resulting consequences, if any, may impact our internal controls and reputation, as well as our business, financial condition, or results of operations.

We are subject to a shareholder class action lawsuit which may adversely affect our business, financial condition, results of operations and cash flows.

We and certain of our current and former executive officers are defendants in a securities class action lawsuit. This lawsuit, including its current status, is described in Part II, Item 1 “Legal Proceedings” in this Quarterly Report. While we believe this lawsuit to be without merit and intend to vigorously defend it, we are in the early stages of this case and we cannot guarantee any particular outcome. This and any similar future matters may divert our attention from our ordinary business operations, and we may incur significant expenses associated with it (including, without limitation, substantial attorneys’ fees and other fees of professional advisors and potential indemnification obligations). Depending on the outcome of such matter, we could be required to pay material damages and/or suffer other penalties, remedies or sanctions. Accordingly, the ultimate resolution of this pending matter or any similar future matters could have a material adverse effect on our business, financial condition, results of operations, cash flows, and/or liquidity and could negatively impact the trading price of our common stock. Any existing or future shareholder lawsuits could also materially adversely affect our reputation and our business, financial condition, or results of operations.

Our substantial international operations subject us to risks not faced by domestic competitors.

Sales from international markets represent a significant portion of our net sales. Accordingly, our business is subject to increasing risks related to the different legal, political, social and regulatory requirements and economic conditions of many jurisdictions. Risks inherent to our international operations include the following:

  • increased credit risk and different financial conditions, which may necessitate longer payment cycles of accounts receivable or result in increased bad debt write-offs (including due to bankruptcy) or additions to reserves;
  • additional withholding taxes or otherwise tax our foreign income, tariffs, duties, export controls, import restrictions or other restrictions on foreign trade or investment, including currency exchange controls;
  • foreign exchange controls or other currency restrictions and limitation on the movement of funds, including the prohibition of the repatriation of funds, which may result in adverse tax consequences and tax inefficiencies;
  • export licenses may be difficult to obtain, and the transportation of our products may be delayed or interrupted;
  • general economic and political conditions in the countries in which we operate, including devaluation or fluctuations in the value of currencies, gross domestic product, interest rates, market demand, labor costs and other factors beyond our control;
  • unexpected adverse changes in foreign laws or in foreign regulatory requirements, including in laws or regulatory requirements pertaining to employee benefits, the environment and health and safety;
  • protectionist policies, which may restrict or impair the manufacturing, sales or import and export of our products;
  • new restrictions on access to markets, such as adverse trade policies or trade barriers;
  • a lack of or inadequate infrastructure;
  • natural disasters or other crises;
  • reduced protection of intellectual property rights in some countries;
  • expropriation of assets or forced relocations of operations;
  • inflation and hyperinflationary economic conditions and adverse economic effects resulting from governmental attempts to control inflation, such as imposition of wage and price controls and higher interest rates;
  • the requirement to comply with a wide variety of foreign and U.S. laws and regulations that apply to international operations, including, without limitation, economic sanctions regulations, labor laws, import and export regulations, anti-corruption and anti-bribery laws;
  • challenges in maintaining an effective internal control environment with operations in multiple international locations, including language differences, varying levels of GAAP expertise in international locations and multiple financial information systems; and
  • labor disruptions, civil unrest, significant social, political or economic instability, wars or other armed conflict or acts of terrorism.

Should any of these risks occur, our ability to manufacture, source, sell or export our products or repatriate profits could be impaired; we could experience a loss of sales and profitability from our international operations; and/or we could experience a substantial impairment or loss of assets, any of which could have a material adverse impact on our business, financial condition, or results of operations.

Furthermore, some of our international operations are conducted in parts of the world that experience corruption to some degree. Although we have policies and procedures in place that are designed to promote legal and regulatory compliance (including with respect to the FCPA and the Bribery Act as further described above), our employees, distributors and wholesalers could take actions in contravention of our policies and procedures that violate applicable anti-corruption laws or regulations. Violations of these laws, or allegations of such violations, could have a material adverse affect on our reputation, our business, financial condition, or results of operations.

We also may face difficulties managing and administering an internationally dispersed business. In particular, the management of our personnel across many countries can present legal, logistical and managerial challenges. Additionally, international operations present challenges related to operating under different business cultures and languages. Our overall success as a global business depends, in part, upon our ability to succeed in different legal, regulatory, economic, social and political conditions.

The results of the United Kingdom’s referendum on withdrawal from the E.U. may have a negative effect on global economic conditions, financial markets and our business, which could reduce the price of our shares of common stock.

We are a multinational company with worldwide operations, including significant business operations in Europe. In June 2016, a majority of voters in the United Kingdom elected to withdraw from the E.U. in a national referendum, commonly referred to as "Brexit." The referendum was advisory, and the terms of any withdrawal are subject to a negotiation period that could last at least two years after the government of the United Kingdom formally initiates a withdrawal process. Nevertheless, the referendum has created significant uncertainty about the future relationship between the United Kingdom and the E.U., and has given rise to calls for certain regions within the United Kingdom to preserve their place in the E.U. by separating from the United Kingdom as well as for the governments of other E.U. member states to consider withdrawal.

These developments, or the perception that any of them could occur, have had and may continue to have a material adverse effect on global economic conditions and the stability of global financial markets, and could significantly reduce global market liquidity and restrict the ability of key market participants to operate in certain financial markets. Asset valuations, currency exchange rates and credit ratings may be especially subject to increased market volatility. Lack of clarity about future United Kingdom laws and regulations as the United Kingdom determines which E.U. laws to replace or replicate in the event of a withdrawal, including financial laws and regulations, tax and free trade agreements, intellectual property rights, supply chain logistics, environmental, health and safety laws and regulations, immigration laws and employment laws, could decrease foreign direct investment in the United Kingdom, increase costs, depress economic activity and restrict our access to capital. If the United Kingdom and the E.U. are unable to negotiate acceptable withdrawal terms or if other E.U. member states pursue withdrawal, barrier-free access between the United Kingdom and other E.U. member states or among the European economic area overall could be diminished or eliminated. Any of these factors could have a material adverse effect on our business, financial condition or results of operations and reduce the price of our shares of common stock.

We are exposed to fluctuations in currency exchange rates, which may adversely affect our operating results and may significantly affect the comparability of our results between financial periods.

Our consolidated financial statements are reported in U.S. Dollars while a significant proportion of our assets, liabilities and earnings are denominated in non-U.S. Dollar currencies. As a result, we are exposed to foreign currency exchange rate fluctuations from translating certain of our foreign subsidiaries’ financial statements. Fluctuations in the value of local currencies in which we derive significant net sales may also impact the U.S. Dollar amounts reflected in our financial statements. Such U.S. Dollar amounts may obscure underlying financial trends that would be apparent in financial statements prepared on a constant currency basis or affect the comparability of our results between financial periods.

The announcement of Brexit caused significant volatility in global stock markets and currency exchange rate fluctuations that resulted in the strengthening of the U.S. Dollar against foreign currencies in which we conduct business. The strengthening of the U.S. Dollar relative to other currencies may adversely affect our business, financial condition, or results of operations, and expose us to gains and losses on non-U.S. currency transactions. In addition, a potential devaluation of the local currencies of our customers relative to the U.S. Dollar may impair the purchasing power of our customer and could cause customers to decrease or cancel orders or default on payment. This volatility in foreign currencies is expected to continue as the United Kingdom negotiates and executes its exit from the E.U. but it is uncertain over what time period this will occur. Any of these effects of Brexit, among others, could adversely affect our business, financial condition, results of operations and cash flows.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-07-01 to 2016-09-30$890.5mus-gaap:SalesRevenueNet
Revenue9 months2016-01-01 to 2016-09-30$2.64bnus-gaap:SalesRevenueNet
Cost of revenue3 months2016-07-01 to 2016-09-30$515.4mus-gaap:CostOfGoodsSold
Cost of revenue9 months2016-01-01 to 2016-09-30$1.52bnus-gaap:CostOfGoodsSold
Gross profit3 months2016-07-01 to 2016-09-30$375.1mus-gaap:GrossProfit
Gross profit9 months2016-01-01 to 2016-09-30$1.11bnus-gaap:GrossProfit
Research and development3 months2016-07-01 to 2016-09-30$20.9mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2016-01-01 to 2016-09-30$61.3mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2016-07-01 to 2016-09-30$274.3mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2016-01-01 to 2016-09-30$823.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2016-07-01 to 2016-09-30$79.9mus-gaap:OperatingIncomeLoss
Operating income9 months2016-01-01 to 2016-09-30$227.0mus-gaap:OperatingIncomeLoss
Income tax3 months2016-07-01 to 2016-09-30$20.4mus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2016-01-01 to 2016-09-30$65.7mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-07-01 to 2016-09-30$71.8mus-gaap:NetIncomeLoss
Net income9 months2016-01-01 to 2016-09-30−$71.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2016-07-01 to 2016-09-30−$0.15us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2016-01-01 to 2016-09-30−$0.71us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-07-01 to 2016-09-30$0.45us-gaap:EarningsPerShareBasic
Basic EPS9 months2016-01-01 to 2016-09-30−$0.17us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-07-01 to 2016-09-30264,500,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2016-01-01 to 2016-09-30253,300,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2016-01-01 to 2016-09-30−$24.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2016-01-01 to 2016-09-30$32.8mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2016-09-30$714.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-09-30$2.60bnus-gaap:AssetsCurrent
Total assetsAt period end2016-09-30$10.93bnus-gaap:Assets
Current liabilitiesAt period end2016-09-30$1.57bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-09-30$7.87bnus-gaap:Liabilities
Shareholders' equityAt period end2016-09-30$2.89bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001590714-16-000248. Last ingested by Listed: Nov 10, 2026, 23:30 ET. Listed shows no prices and gives no investment advice.